147 related articles for article (PubMed ID: 17089722)
61. Effect of exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and polychlorinated biphenyls (PCBs) on mitochondrial DNA (mtDNA) copy number in rats.
VanEtten SL; Bonner MR; Ren X; Birnbaum LS; Kostyniak PJ; Wang J; Olson JR
Toxicology; 2021 Apr; 454():152744. PubMed ID: 33677009
[TBL] [Abstract][Full Text] [Related]
62. 3,3',4,4',5-Pentachlorobiphenyl (PCB 126) impacts hepatic lipid peroxidation, membrane fluidity and beta-adrenoceptor kinetics in chick embryos.
Katynski AL; Vijayan MM; Kennedy SW; Moon TW
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Jan; 137(1):81-93. PubMed ID: 14984707
[TBL] [Abstract][Full Text] [Related]
63. Analysis of the CYP1A1 mRNA dose-response in human keratinocytes indicates that relative potencies of dioxins, furans, and PCBs are species and congener specific.
Sutter CH; Bodreddigari S; Sutter TR; Carlson EA; Silkworth JB
Toxicol Sci; 2010 Dec; 118(2):704-15. PubMed ID: 20819910
[TBL] [Abstract][Full Text] [Related]
64. Sensitivity of lake sturgeon (Acipenser fulvescens) early life stages to 2,3,7,8-tetrachlorodibenzo-P-dioxin and 3,3',4,4',5-pentachlorobiphenyl.
Tillitt DE; Buckler JA; Nicks DK; Candrl JS; Claunch RA; Gale RW; Puglis HJ; Little EE; Linbo TL; Baker M
Environ Toxicol Chem; 2017 Apr; 36(4):988-998. PubMed ID: 27600767
[TBL] [Abstract][Full Text] [Related]
65. Factorial design applied for multiple endpoint toxicity evaluation in Atlantic salmon (Salmo salar L.) hepatocytes.
Søfteland L; Eide I; Olsvik PA
Toxicol In Vitro; 2009 Dec; 23(8):1455-64. PubMed ID: 19607907
[TBL] [Abstract][Full Text] [Related]
66. Nonresponsiveness to 2,3,7,8-tetrachlorodibenzo-p-dioxin of transforming growth factor beta1 and CYP 1A1 gene expression in rat liver fat-storing cells.
Riebniger D; Schrenk D
Toxicol Appl Pharmacol; 1998 Sep; 152(1):251-60. PubMed ID: 9772220
[TBL] [Abstract][Full Text] [Related]
67. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
68. Altered thyroxin and retinoid metabolic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in aryl hydrocarbon receptor-null mice.
Nishimura N; Yonemoto J; Miyabara Y; Fujii-Kuriyama Y; Tohyama C
Arch Toxicol; 2005 May; 79(5):260-7. PubMed ID: 15902423
[TBL] [Abstract][Full Text] [Related]
69. In ovo 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure in three avian species. 2. Effects on estrogen receptor and plasma sex steroid hormones during the perinatal period.
Janz DM; Bellward GD
Toxicol Appl Pharmacol; 1996 Aug; 139(2):292-300. PubMed ID: 8806845
[TBL] [Abstract][Full Text] [Related]
70. Biochemical and molecular biological analysis of different responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo heart and liver.
Kanzawa N; Kondo M; Okushima T; Yamaguchi M; Temmei Y; Honda M; Tsuchiya T
Arch Biochem Biophys; 2004 Jul; 427(1):58-67. PubMed ID: 15178488
[TBL] [Abstract][Full Text] [Related]
71. Regulation of rat carboxylesterase expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): a dose-dependent decrease in mRNA levels but a biphasic change in protein levels and activity.
Yang D; Li Y; Yuan X; Matoney L; Yan B
Toxicol Sci; 2001 Nov; 64(1):20-7. PubMed ID: 11606798
[TBL] [Abstract][Full Text] [Related]
72. Toxic potency of 3,3',4,4',5-pentachlorobiphenyl relative to and in combination with 2,3,7,8-tetrachlorodibenzo-p-dioxin in a subchronic feeding study in the rat.
Van Birgelen AP; Van der Kolk J; Fase KM; Bol I; Poiger H; Brouwer A; Van den Berg M
Toxicol Appl Pharmacol; 1994 Aug; 127(2):209-21. PubMed ID: 8048064
[TBL] [Abstract][Full Text] [Related]
73. Correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in vascular endothelium with toxicity in early life stages of lake trout.
Guiney PD; Smolowitz RM; Peterson RE; Stegeman JJ
Toxicol Appl Pharmacol; 1997 Apr; 143(2):256-73. PubMed ID: 9144443
[TBL] [Abstract][Full Text] [Related]
74. RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone.
Abbott BD; Schmid JE; Brown JG; Wood CR; White RD; Buckalew AR; Held GA
Toxicol Sci; 1999 Jan; 47(1):76-85. PubMed ID: 10048155
[TBL] [Abstract][Full Text] [Related]
75. Preferential inducibility of CYP1A1 and CYP1A2 by TCDD: differential regulation in primary human hepatocytes versus transformed human cells.
Zhang ZY; Pelletier RD; Wong YN; Sugawara M; Zhao N; Littlefield BA
Biochem Biophys Res Commun; 2006 Mar; 341(2):399-407. PubMed ID: 16426572
[TBL] [Abstract][Full Text] [Related]
76. Time-dependent transcriptomic and biochemical responses of 6-formylindolo[3,2-b]carbazole (FICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are explained by AHR activation time.
Farmahin R; Crump D; O'Brien JM; Jones SP; Kennedy SW
Biochem Pharmacol; 2016 Sep; 115():134-43. PubMed ID: 27301797
[TBL] [Abstract][Full Text] [Related]
77. Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatocyte cultures.
Schrenk D; Stüven T; Gohl G; Viebahn R; Bock KW
Carcinogenesis; 1995 Apr; 16(4):943-6. PubMed ID: 7537183
[TBL] [Abstract][Full Text] [Related]
78. Human and rat primary hepatocyte CYP1A1 and 1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8-pentachlorodibenzofuran.
Budinsky RA; LeCluyse EL; Ferguson SS; Rowlands JC; Simon T
Toxicol Sci; 2010 Nov; 118(1):224-35. PubMed ID: 20705892
[TBL] [Abstract][Full Text] [Related]
79. Evidence of spatially extensive resistance to PCBs in an anadromous fish of the Hudson River.
Yuan Z; Courtenay S; Chambers RC; Wirgin I
Environ Health Perspect; 2006 Jan; 114(1):77-84. PubMed ID: 16393662
[TBL] [Abstract][Full Text] [Related]
80. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
